Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Cecchini

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
JNCI Cancer Spectrum|January 7, 2026
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivorsFaiza Yasin, Sarah J Westvold, Jessica B Long, et al.
Annals of Surgical Oncology|March 28, 2026
ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Annals of Surgical Oncology|February 3, 2026
Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal CancerMichael Cecchini, Sae-Won Han, Soohyeon Lee, et al.
Annals of Surgical Oncology|February 24, 2026
ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
JCO Clinical Cancer Informatics|August 16, 2024
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic CancerSunkyu Kim, Seung-Seob Kim, Eejung Kim, et al.
Plos One|December 21, 2022
Impact of early detection on cancer curability: A modified Delphi panel studyLee Schwartzberg, Michael S Broder, Sikander Ailawadhi, et al.
JCO Precision Oncology|April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Cancer|December 22, 2020
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancerMichael Cecchini, Jeremy S Kortmansky, Can Cui, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
JNCI Cancer Spectrum|January 7, 2026
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivorsFaiza Yasin, Sarah J Westvold, Jessica B Long, et al.
Annals of Surgical Oncology|March 28, 2026
ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Annals of Surgical Oncology|February 3, 2026
Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2026
The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal CancerMichael Cecchini, Sae-Won Han, Soohyeon Lee, et al.
Annals of Surgical Oncology|February 24, 2026
ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal MetastasesPrincy Gupta, Elizabeth L Godfrey, Kurt S Schultz, et al.
JCO Clinical Cancer Informatics|August 16, 2024
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic CancerSunkyu Kim, Seung-Seob Kim, Eejung Kim, et al.
Plos One|December 21, 2022
Impact of early detection on cancer curability: A modified Delphi panel studyLee Schwartzberg, Michael S Broder, Sikander Ailawadhi, et al.
JCO Precision Oncology|April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Cancer|December 22, 2020
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancerMichael Cecchini, Jeremy S Kortmansky, Can Cui, et al.
Pageof 7